![Screen Shot 2020-03-25 at 2.47.30 PM Screen Shot 2020-03-25 at 2.47.30 PM](http://chemneuro.martinos.org/wp-content/uploads/2020/08/Screen-Shot-2020-03-25-at-2.47.30-PM-100x100.png)
Publications
Below are the most recent publications from the Chemical Neuroscience Program. All other published works can be found here.
- Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept study
- Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease
- Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A
- PET-MRI Applications and Future Prospects in Psychiatry
- A Fast-Binding, Functionally Reversible, COX-2 Radiotracer for CNS PET Imaging
- Investigating neuroepigenetic alterations in chronic low back pain with positron emission tomography
- Impact of repeated blast exposure on active-duty United States Special Operations Forces
- Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia
- In vivo translocator protein in females with autism spectrum disorder: a pilot study
- Molecular Imaging of Alzheimer's Disease-Related Sigma-1 Receptor in the Brain via a Novel Ru-Mediated Aromatic 18F-deoxyfluorination Probe
- Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds
- Synthesis and preclinical evaluation of 11C-labeled 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine radioligands for RIPK1 positron emission tomography imaging
- Synthesis and Characterization of a New Carbon-11 Labeled Positron Emission Tomography Radiotracer for Orexin 2 Receptors Neuroimaging
- Characterization of cortico-meningeal translocator protein expression in multiple sclerosis
- Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold
- Preliminary Exploration of Pseudo-CT-Based Attenuation Correction for Simultaneous PET/MRI Brain Imaging in Nonhuman Primates
- In vivo three-dimensional brain imaging with chemiluminescence probes in Alzheimer's disease models
- Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology
- Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice
- Author Correction: The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption